Entyvio vs Humira (Vedolizumab Vs Adalimumab) is a head to head comparison of the two tumor necrosis factor inhibitors (TNF inhibitors) in the treatment of patients with inflammatory bowel diseases. Entyvio is a humanized IgG1 monoclonal antibody that acts against α4β7 integrin which plays a main role in gastrointestinal inflammation. While Humira is a TNF … Read more
Biologics for Psoriasis are used in patients who have moderate to severe disease or are not responsive to conventional therapies. Biologics for psoriasis are both effective and tolerable. They have good short-term and long-term efficacy. The most common side effect associated with the use of biologics for psoriasis is the increased incidence of infections. TNF-alpha … Read more
TNF inhibitors are being increasingly used in the treatment of various immune-mediated diseases such as rheumatoid arthritis, ankylosing spondylitis, inflammatory bowel diseases, and psoriasis. There are five tumor necrosis factor inhibitors available to treat rheumatoid arthritis and other immune-mediated diseases worldwide. Biosimilar versions of TNF inhibitors are now available in certain countries. Additional biosimilar agents … Read more